VolitionRX Limited (VNRX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Volitionrx Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.652 Hello everyone and thank you for standing by. 00:00:02.652 -- 00:00:08.974 Welcome to VolitionRX Limited's second quarter 2026 earnings conference call. 00:00:08.974 -- 00:00:13.256 During today's presentation, all parties will be in a listen only mode. 00:00:13.256 -- 00:00:17.877 Following the presentation, the conference call will be open for questions. 00:00:17.877 -- 00:00:21.619 If you have a question, please press the star key followed by the number one on your 00:00:21.619 -- 00:00:23.739 touch tone phone. 00:00:23.739 -- 00:00:27.621 If you would like to withdraw your question, please press the star key followed by the 00:00:27.621 -- 00:00:29.409 number two. 00:00:29.409 -- 00:00:34.592 If you're using speaker equipment, please flip the handset before making your selections. 00:00:34.592 -- 00:00:39.794 This conference call is being recorded today, August 14th, 2026. 00:00:40.156 -- 00:00:44.919 I'd now like to turn the conference call over to Louise Batchelor, Group Chief Marketing 00:00:44.919 -- 00:00:48.541 and Communications Officer. Please go ahead. 00:00:48.541 -- 00:00:53.284 Welcome everyone to today's earnings conference call for VolitionRX Limited. 00:00:53.284 -- 00:00:57.726 Before we begin, I'd like to remind everyone that some of the information discussed on 00:00:57.726 -- 00:01:02.763 this conference call will include forward-looking statements covered under the safe 00:01:02.763 -- 00:01:08.825 harbour provisions of the Private Securities Litigation Reform Act of 1995. 00:01:08.825 -- 00:01:14.007 These statements are based on our beliefs, as well as assumptions we have used based 00:01:14.007 -- 00:01:17.249 upon information currently available to us. 00:01:17.249 -- 00:01:22.171 Because these statement...